Outcomes of Intraoperative 5-Fluorouracil Versus Mitomycin C
Status:
Completed
Trial end date:
2007-08-01
Target enrollment:
Participant gender:
Summary
A clinical trial to establish the long term response of using intraoperative 5-fluorouracil
(5-FU) versus mitomycin C (MMC) in trabeculectomy glaucoma surgery. Antiproliferative agents
such as 5-fluorouracil and Mitomycin C have been used extensively in trabeculectomy surgery
to improve the success of the surgery and prevent further visual loss and blindness in
glaucoma patients.